- 201. Nafoxidine
- [A triphenylethylene nonsteroidal agent that acts as a partial estrogen antagonist. Nafoxidine competes with endogenous estrogen for binding to specific estrogen receptors. This agent also inhibits angiogenesis in some tissues by blocking the effects of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF); paradoxically, it may enhance angiogenesis in uterine tissue. Nafoxidine also induces oxidative stress, protein kinase C and calcium signaling. (NCI04) ( NCI )] (UMLS (NCI) C0027328) =Organic Chemical; Pharmacologic Substance
| - 251. Nanomaterial
- [A bulk material composed of discrete nano-substructures that are engineered, synthesized and characterized for a myriad of applications. ( NCI )] (UMLS (NCI) C1450053) =Manufactured Object ;
|
- 202. NAG
- [This gene may play a role in the development of neuroblastoma. ( NCI )] (UMLS (NCI) C1334861) NAG Gene;
Neuroblastoma-Amplified Protein Gene;
=Gene or Genome ;
| - 252. nanomedicine
- [health related nanotechnology application. ( CSP )] (UMLS (CSP) C1328814) =Occupation or Discipline ;
=Nanoscale Science;
|
- 203. nagana
- [ ] (UMLS (CSP) C0027333) =Disease or Syndrome ;
| - 253. Nanometer
- [A metric unit of length equal to to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement. ( NCI )] (UMLS (NCI) C0439202) =Quantitative Concept
|
- 204. Naganin
- (UMLS (NCI) C0878166) =Organic Chemical; Pharmacologic Substance
| - 254. NANOMOLE
- [LITERAL ( NCI )] (UMLS (NCI) C0439191) =Quantitative Concept
|
- 205. Naganol
- (UMLS (NCI) C0878165) =Organic Chemical; Pharmacologic Substance
| - 255. Nanoparticle
- [A small, stable particle whose size is measured in nanometers. These particles are used in various biomedical applications in which they can be utilized as drug carriers or imaging agents. Various targeting agents, such as antibodies, drugs, imaging agents, and reporters can be attached to the surface of a nanoparticle. ( NCI )] (UMLS (NCI) C1450054) =Manufactured Object ;
|
- 206. nagarse
- [ ] (UMLS (CSP) C0038599) =Amino Acid, Peptide, or Protein; Enzyme
| - 256. Nanoscale Science
- [science involved with manufacturing or engineering one atom or molecule at a time with precise atomic specifications; concerned with materials and systems whose structures and components exhibit novel and significantly improved physical, chemical and biological properties, phenomena and processes because of their small nanoscale size; includes technology to generate and use nanostructures and nanodevices; do not index on projects simply observing and describing physical characteristics at the nanoscale level. ( CSP )] (UMLS (NCI) C0872323) Nanotech;
nanotechnology =Occupation or Discipline ;
=bioengineering;
tag term =nanomedicine;
|
- 207. nagarse proteinase
- [ ] (UMLS (CSP) C0599498) =Amino Acid, Peptide, or Protein; Enzyme
| - 257. Nanosphere
- [Self-assembling durable silica spheres that fit inside each other. These spheres range in size from 2 to 50 nanometers and form within seconds. They are small enough to be introduced into the body and have uniform pores that facilitate the controlled release of drugs. The spheres also have the capability to absorb both organic and inorganic substances. For example, nanoparticles can absorb small particles of iron, thereby allowing magnetic control. Thus, the contents of nanospheres can be released upon activation. ( NCI )] (UMLS (NCI) C1257852) =Manufactured Object ;
|
- 208. nail
- [The thin, horny plates that cover the dorsal surfaces of the distal phalanges of the fingers and toes of primates. ( MSH )] (UMLS (CSP) C0027342) =Body Part, Organ, or Organ Component ;
=Body Part;
| - 258. Nanotube
- [Fullerene-like nanostructures that consist of graphene cylinders. The ends of the construct are closed with pentagonal-shaped rings. ( NCI )] (UMLS (NCI) C1257851) =Manufactured Object ;
|
- 209. Nail
- (UMLS (HL7) C0444077) =Body Substance ;
=SpecimenEntityType;
◊ (UMLS (HL7) C1546715) Intellectual Product Specimen Source Codes; | - 259. NAP2
- [Encoded by human PPBP Gene (Alpha Chemokine CXC Family), secreted 128-aa 14-kDa (precursor) Pro-Platelet Basic Protein is a platelet-derived growth factor that is processed to PBP and CTAP-III. Proteolytic removal of PPBP residues 1-9 produces active peptide CTAP-III/LA-PF4, which stimulates DNA synthesis, mitosis, glycolysis, intracellular cAMP accumulation, prostaglandin E2 secretion, and synthesis of hyaluronic acid and sulfated glycosaminoglycan, as well as formation and secretion of plasminogen activator. Upon platelet activation, PBP is proteolytically converted to beta thromboglobulin, a homotetramer released when platelets aggregate; CTAP-III is proteolytically converted to NAP2, a potent chemoattractant and activator of neutrophils. (NCI) ( NCI )] (UMLS (NCI) C0132309) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 210. NAIL ANOMALIES NEC
- [ ] (UMLS (ICD9CM) C0432351) =Congenital Abnormality
| - 260. NAPHAZOLINE
- [An imidazole derivative and a direct-acting sympathomimetic amine with vasoconstrictive activity. Upon ocular administration, naphazoline exerts its effect by acting on alpha-adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, resulting in decreased conjunctival congestion and diminished itching, irritation and redness. ( NCI )] (UMLS (NCI) C0027373) =Organic Chemical; Pharmacologic Substance ;
=imidazole;
[OP800] DECONGESTANTS, TOPICAL OPHTHALMIC =1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, Monohydrochloride |
- 211. Nail Bed
- (UMLS (HL7) C0221997) =Body Part, Organ, or Organ Component =Body Part;
| - 261. naphtha
- [ ] (UMLS (CSP) C0068407) =Organic Chemical; Hazardous or Poisonous Substance ;
|
- 212. Nail changes
- (UMLS (NCI) C0234909) =Finding
| - 262. naphthalene
- [two-ring crystalline aromatic hydrocarbons isolated from coal tar; used as intermediates in chemical synthesis, as insect repellents, fungicides, lubricants, and preservatives. ( CSP )] (UMLS (CSP) C0027378) =Organic Chemical =carbopolycyclic compound;
PAH =(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester;
6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid;
Mayapple Extract;
1-Naphthylamine;
(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester;
Naphthaleneacetic Acids;
Naphthalenesulfonates;
naphthol;
naphthoquinone;
Tetrahydronaphthalenes;
Carbamothioic Acid, methyl(3-methylphenyl)-, O-2-naphthalenyl Ester;
(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine;
[1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-1,2,6,7,8,8a-Hexahydro-beta,!d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic Acid;
butenafine;
6-(3-(1-Adamantyl)-4-methoxyphenyl)-2-naphthoic acid |
- 213. nail patella syndrome
- [A syndrome of multiple abnormalities characterized by the absence or hypoplasia of the PATELLA and congenital nail dystrophy. It is a genetically determined autosomal dominant trait. ( MSH )] (UMLS (CSP) C0027341) =Congenital Abnormality; Disease or Syndrome =Abnormalities, Multiple;
DISEASE OF NAIL NOS | - 263. Naphthalene
- [A white, volatile, solid polycyclic hydrocarbon with a strong mothball odor. Naphthalene is obtained from either coal tar or petroleum distillation and is primarily used to manufacture phthalic anhydride, but is also used in moth repellents. Exposure to naphthalene is associated with hemolytic anemia, damage to the liver and neurological system, cataracts and retinal hemorrhage. Naphthalene is reasonably anticipated to be a human carcinogen and may be associated with an increased risk of developing laryngeal and colorectal cancer. (NCI05) ( NCI )] (UMLS (NCI) C0027375) =Organic Chemical
|
- 214. NAIL REMOVAL
- [ ] (UMLS (ICD9CM) C0177698) =Therapeutic or Preventive Procedure
| - 264. naphthol
- [Naphthalene derivatives carrying one or more hydroxyl (-OH) groups at any ring position. They are often used in dyes and pigments, as antioxidants for rubber, fats, and oils, as insecticides, in pharmaceuticals, and in numerous other applications. ( MSH )] (UMLS (CSP) C0027387) =Organic Chemical =naphthalene;
=[AM250] TETRACYCLINES;
|
- 215. Nail, Toe
- (UMLS (HL7) C0222007) =Body Part, Organ, or Organ Component =Body Part;
| - 265. naphthoquinone
- [naphthalene rings which contain two ketone moieties in any position. ( CSP )] (UMLS (CSP) C0027388) =Organic Chemical =naphthalene;
Benzoquinone Compound =[VT700] VITAMIN K;
ATOVAQUONE |
- 216. NailRoute
- [Nail ( HL7V3.0 )] (UMLS (HL7) C1700804) =Functional Concept ;
=RouteBySite;
=Topical application, nail;
| - 266. naphthylamine
- [nitrogen substituted aromatic hydrocarbon existing as two different isomers, both carcinogenic and used in dyes. ( CSP )] (UMLS (CSP) C0260030) =Organic Chemical ;
=cyclic amine;
=1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol |
- 217. Nairobi sheep disease virus
- [A species of NAIROVIRUS, transmitted by the ixodid ticks and producing a lethal gastroenteritis in sheep and goats. Though a major veterinary pathogen, its effect on humans has not been firmly established. ( MSH )] (UMLS (CSP) C0027346) =Virus ;
| - 267. naphthyridine
- [ ] (UMLS (CSP) C0178756) =Organic Chemical ;
|
- 218. Nairovirus
- [A genus of the family BUNYAVIRIDAE named after NAIROBI SHEEP DISEASE, an acute, hemorrhagic, tick-borne, gastroenteritis affecting sheep and goats. The type species is Dugbe virus. Some viruses in this genus are capable of causing severe and fatal disease in humans. ( MSH )] (UMLS (CSP) C0085381) =Virus
| - 268. Naphuride
- (UMLS (NCI) C0242512) =Organic Chemical; Pharmacologic Substance
|
- 219. NAK
- [Encoded by human TBK1 Gene, 729-aa 84-kDa TANK-Binding Kinase 1 (similar to IKB kinases) mediates NFKB activation in response to certain growth factors. TBK1 forms a complex with TRAF2 and TANK IKB protein to release NFKB inhibition by TANK. NFKB complex is inhibited by IKB proteins, which trap it in the cytoplasm. IKB serine phosphorylation by IKB kinases marks them for ubiquitinated destruction, allowing NFKB activation and nuclear translocation. (NCI) ( NCI )] (UMLS (NCI) C0911531) NF-KB-Activating Kinase;
NF-KB-Activating Kinase NAK;
T2K;
TANK Binding Kinase TBK1;
TANK-Binding Kinase 1;
TBK1 =Amino Acid, Peptide, or Protein; Enzyme | - 269. Naprosyn
- (UMLS (NCI) C0700017) =Organic Chemical; Pharmacologic Substance ;
|
- 220. Naknek Native Village
- (UMLS (HL7) C1550923) =Population Group =NativeEntityAlaska;
| - 270. Naqua
- (UMLS (NCI) C0740163) =Organic Chemical; Pharmacologic Substance ;
|
- 221. Nakoda
- (UMLS (HL7) C1551961) Nakota;
Nakota Sioux =Language =Dakotan;
| - 271. NARATRIPTAN
- (UMLS (NCI) C0540623) =Organic Chemical; Pharmacologic Substance ;
=Indole;
Piperidines;
[CN105] ANTIMIGRAINE AGENTS;
=GR 85548A |
- 222. NALBUPHINE
- [A narcotic used as a pain medication. It appears to be an agonist at kappa opioid receptors and an antagonist or partial agonist at mu opioid receptors. ( MSH )] (UMLS (NCI) C0027348) =Organic Chemical; Pharmacologic Substance =[CN101] OPIOID ANALGESICS;
morphinan =(5alpha,6alpha)-17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol Hydrochloride | - 272. Narcan
- (UMLS (NCI) C0684237) =Organic Chemical; Pharmacologic Substance
|
- 223. Nalmefene
- (UMLS (NCI) C0068377) =Organic Chemical; Pharmacologic Substance ;
=NALTREXONE;
[CN102] OPIOID ANTAGONIST ANALGESICS =Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, Hydrochloride,(5alpha)- | - 273. narcissine
- [ ] (UMLS (CSP) C0598686) =Organic Chemical
|
- 224. nalorphine
- [narcotic antagonist with some agonist properties; an antagonist at mu opioid receptors and an agonist at kappa opioid receptors. ( CSP )] (UMLS (CSP) C0027355) =Organic Chemical; Pharmacologic Substance ;
=MORPHINE;
Narcotic Antagonist | - 274. NARCISSISTIC PERSONALITY
- (UMLS (ICD9CM) C0027402) =Mental or Behavioral Dysfunction ;
|
- 225. NALTREXONE
- [synthetic congener of oxymorphone, chemically related to naloxone; a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction and alcohol dependence. ( CSP )] (UMLS (NCI) C0027360) =Organic Chemical; Pharmacologic Substance ;
=morphinan;
(-)-Naloxone;
Narcotic Antagonist;
[CN102] OPIOID ANTAGONIST ANALGESICS =Nalmefene;
(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride;
| - 275. NARCLPSY W/O CAT OTH DIS
- [ ] (UMLS (ICD9CM) C1456241) Narcolepsy in conditions classified elsewhere, without cataplexy;
=Disease or Syndrome ;
|
- 226. naltrindole
- [ ] (UMLS (CSP) C0068389) =Organic Chemical; Pharmacologic Substance ;
| - 276. NARCOANALYSIS
- [ ] (UMLS (ICD9CM) C1281603) =Therapeutic or Preventive Procedure
|
- 227. Name
- [For attributes that represent a name by which an instance of the class is known. ( HL7V3.0 )] (UMLS (HL7) C1554107) =Idea or Concept =MDFAttributeType;
| - 277. Narcolepsy in conditions classified elsewhere
- [ ] (UMLS (ICD9CM) C1456243) =Disease or Syndrome ;
|
- 228. Name
- [The words or language units by which a thing is known. ( NCI )] (UMLS (NCI) C0027365) =Intellectual Product
| - 278. Narcolepsy in conditions classified elsewhere, with cataplexy
- [ ] (UMLS (ICD9CM) C1456242) NARCOLEPSY W CAT OTH DIS;
=Disease or Syndrome ;
|
- 229. Name assembly order
- (UMLS (HL7) C1547824) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Prefix Family Middle Given Suffix;
Prefix Given Middle Family Suffix | - 279. NARCOLEPSY W/O CATAPLEXY
- [ ] (UMLS (ICD9CM) C1456240) Narcolepsy, without cataplexy;
=Disease or Syndrome ;
|
- 230. Name at Birth
- (UMLS (HL7) C1549652) =Idea or Concept =Name type;
| - 280. Narcotan
- (UMLS (NCI) C0701983) =Organic Chemical; Pharmacologic Substance ;
|
- 231. Name context
- (UMLS (HL7) C1547828) =Idea or Concept =HL7 Vocabulary Version 2.5;
| - 281. Narcotic
- [agent that produces insensibility, somnolence or induces sleep; especially, any derivative, natural or synthetic, of opium or morphine or any substance that has their effects; narcotics have potent analgesic effects associated with significant changes in mood and behavior, and with the potential for dependence and tolerance following repeated administration. ( CSP )] (UMLS (NCI) C0027415) =Pharmacologic Substance; Hazardous or Poisonous Substance =psychopharmacologic agent;
=METHADONE;
opiate alkaloid |
- 232. Name misspelling
- (UMLS (HL7) C1548783) =Qualitative Concept =Specimen Reject Reason;
| - 282. Narcotic Antagonist
- [class of drugs used to treat opiate drug addiction. ( CSP )] (UMLS (NCI) C0027410) =Pharmacologic Substance ;
=drug addiction antagonist;
Opioid Receptor Interactions =buprenorphine;
cyclazocine;
nalorphine;
(-)-Naloxone;
NALTREXONE;
|
- 233. Name of Partner/Spouse (retained for backward compatibility only)
- (UMLS (HL7) C1549659) =Idea or Concept =Name type;
| - 283. narcotic control
- [ ] (UMLS (CSP) C0027411) =Governmental or Regulatory Activity ;
|
- 234. Name type
- (UMLS (HL7) C1547610) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Maiden;
Alias Name;
Name at Birth;
Adopted Name;
Licensing Name;
Nickname /_Call me_ Name/Street Name;
Name of Partner/Spouse (retained for backward compatibility only);
Registered Name (animals only);
Coded Pseudo-Name to ensure anonymity;
Indigenous/Tribal/Community Name;
Unspecified;
Display Name;
Legal Name | - 284. Nardil
- (UMLS (NCI) C0701388) =Organic Chemical; Pharmacologic Substance
|
- 235. Name with location and date
- (UMLS (HL7) C1547374) =Idea or Concept =Data type;
| - 285. Nariva virus
- [ ] (UMLS (CSP) C0318800) =Virus
|
- 236. Name/address change
- (UMLS (HL7) C1546916) =Idea or Concept =Insurance Company Contact Reason;
| - 286. Naroparcil
- (UMLS (NCI) C0294245) =Carbohydrate; Pharmacologic Substance ;
|
- 237. Name/address representation
- (UMLS (HL7) C1547843) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Alphabetic (i.e., Default or some single-byte);
Ideographic (i.e., Kanji);
Phonetic (i.e., ASCII, Katakana, Hiragana, etc.);
| - 287. Narragansett Indian Tribe of Rhode Island
- (UMLS (HL7) C1554387) =Population Group =NativeEntityContiguous;
|
- 238. named group
- [tree section heading term for specific named groups; do not index. ( CSP )] (UMLS (CSP) C0597010) =Population Group =CRISP Thesaurus;
=ethnic group;
Area;
disabled;
migrant;
Job;
veteran;
homeless;
immigrant;
age group;
religious group;
tag term;
medically disadvantaged population | - 288. Narrower Than
- [The first concept is at a more detailed level than the second concept. For example, Pennicillin G is narrower than Pennicillin, and vellus hair is narrower than hair. Narrower than is the opposite of broader than. ( HL7V3.0 )] (UMLS (HL7) C1552873) =Idea or Concept =MapRelationship;
|
- 239. Namenda
- (UMLS (NCI) C1330412) =Organic Chemical; Pharmacologic Substance
| - 289. nasal
- [By or having to do with the nose. ( NCI )] (UMLS (NCI) C0028429) =Body Part, Organ, or Organ Component =Nasopharyngeal;
Body System, Pulmonary;
Body Part;
=Nasal and Sinuses;
|
- 240. NameRepresentationUse
- [Identifies the different representations of a name. The representation may affect how the name is used. (E.g. use of Ideographic for formal communications.) ( HL7V3.0 )] (UMLS (HL7) C1699383) =Classification ;
=OrganizationNameUse;
PersonNameUse =Alphabetic;
Syllabic;
Ideographic | - 290. NASAL & SINUS DIS NEC
- [ ] (UMLS (ICD9CM) C0029581) =Disease or Syndrome
|
- 241. Namespace ID
- (UMLS (HL7) C1547700) =Intellectual Product ;
=HL7 Vocabulary Version 2.5;
| - 291. nasal airflow measurement
- [ ] (UMLS (CSP) C0599318) =Diagnostic Procedure ;
|
- 242. NANDA
- [North American Nursing Diagnosis Association, Philadelphia, PA. ( HL7V3.0 )] (UMLS (HL7) C1140111) =Intellectual Product =Code;
CodeSystem | - 292. Nasal and Sinuses
- [air-filled extensions of the respiratory part of the nasal cavity into the frontal, ethmoid, sphenoid, and maxillary cranial bones, lined by the ciliated mucous membranes of the nasal cavity. ( CSP )] (UMLS (NCI) C0030471) =Body Space or Junction ;
=nasal;
Body Part |
- 243. NANDROLONE DECANOATE
- [The decanoate salt form of nandrolone, an anabolic steroid analog of testosterone with androgenic, anabolic, and erythropoietin stimulating effects. Nandrolone enters the cell and binds to and activates specific nuclear androgen receptors in responsive tissue, including the prostate, seminal vesicles, scrotum, penis, larynx, hair follicles, muscle, and bone. The resulting activated hormone receptor complex translocates into the nucleus and binds to androgen response elements (ARE) in the promoter region of targeted genes, where the complex promotes gene expression necessary for maintaining male sex characteristics. Mimicking the negative feedback mechanism of testosterone, nandrolone decanoate also suppresses the secretion of luteinizing hormone (LH). Furthermore, this agent also stimulates erythropoietin production by enhancing the production of erythropoietic stimulating factors. ( NCI )] (UMLS (NCI) C0068395) =Steroid; Pharmacologic Substance; Hormone =19 nortestosterone;
=NANDROLONE DECANOATE 50 MG/ML;
NANDROLONE DECANOATE 100 MG/ML;
NANDROLONE DECANOATE 200 MG/ML | - 293. nasal bone
- [Either of two small elongated rectangular bones that together form the bridge of the nose. ( MSH )] (UMLS (CSP) C0027422) =Body Part, Organ, or Organ Component ;
|
- 244. NANDROLONE PHENPROPIONATE
- (UMLS (NCI) C0068397) =Steroid; Pharmacologic Substance ;
=19 nortestosterone;
=NANDROLONE PHENPROPIONATE 50 MG/ML;
NANDROLONE PHENPROPIONATE 25 MG/ML;
| - 294. NASAL BONE FX-CLOSED
- [ ] (UMLS (ICD9CM) C0159322) =Injury or Poisoning
|
- 245. Nanirnavirus
- [ ] (UMLS (CSP) C0599135) =Virus
| - 295. NASAL BONE FX-OPEN
- [ ] (UMLS (ICD9CM) C0159323) =Injury or Poisoning
|
- 246. nano
- [A unit prefix indicating a quantity of 10E-9 or one one-billionth. ( NCI )] (UMLS (HL7) C1553036) nano-;
=Quantitative Concept =UnitOfMeasurePrefixSens;
UnitOfMeasurePrefixInsens | - 296. Nasal Cartilage
- (UMLS (NCI) C0225415) =Body Part, Organ, or Organ Component
|
- 247. Nanocurie
- [A unit of radioactivity equal to one billionth of curie or 37 becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second. ( NCI )] (UMLS (NCI) C0560007) =Quantitative Concept
| - 297. Nasal Cavity
- [The proximal portion of the respiratory passages on either side of the nasal septum, lined with ciliated mucosa, extending from the nares to the pharynx. (MeSH) ( NCI )] (UMLS (NCI) C0027423) =Body Space or Junction ;
|
- 248. NANOG
- [This gene plays a role in the underlying pluripotency of inner cell mass and embryonic stem cells. ( NCI )] (UMLS (NCI) C1427164) NANOG Gene;
Nanog Homeobox Gene;
=Gene or Genome ;
| - 298. Nasal Cavity and Paranasal Sinus Disorder
- (UMLS (NCI) C1334924) =Disease or Syndrome ;
|
- 249. Nanogram
- [LITERAL ( NCI )] (UMLS (NCI) C0439212) =Quantitative Concept
| - 299. Nasal Cavity and Paranasal Sinus Neoplasm
- (UMLS (NCI) C1334925) =Neoplastic Process ;
|
- 250. Nanogram per Deciliter
- [A unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume one deciliter. ( NCI )] (UMLS (NCI) C0439274) =Quantitative Concept
| - 300. Nasal Cavity Disease
- (UMLS (NCI) C0339820) =Disease or Syndrome ;
|
home
